Lianhe Ratings Global Limited (“Lianhe Global”) has upgraded the global scale Long-term Issuer Credit Rating of Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (“THPI”) to ‘A’ from ‘A-’; Issuer Rating Outlook Remains Stable
Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (Rating Report)